Business
Bolt Biotherapeutics, Inc. (BOLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Levi & Korsinsky notifies investors that it has c...
About this update from Bolt Metals Corp.
[{"type":"text","content":"Bolt Biotherapeutics, Inc. (BOLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsNEW YORK, NY / ACCESSWIRE / May 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bolt Biotherapeutics, Inc. (\"Bolt Biotherapeutics, Inc.\") (NASDAQ:BOLT) concerning possible violations of federal securities laws.Bolt announced in a press release on May 14, 2024, that the Company would \"cease further development of trastuzumab imbotolimod (BDC-1001)\", Bolt's lead asset, \"and reduce workforce by approximately 50%\". Following Bolt's announcement, multiple analysts downgraded the Company's stock. Following this news, Bolt's stock dropped over 18% on May 15, 2024. To obtain additional information, go to:https://zlk.com/pslra-1/bolt-biotherapeutics-inc-lawsuit-submission-form?prid=82136&wire=1or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212)363-7500.WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY [email protected]: (212)363-7500Fax: (212)363-7171https://zlk.com/SOURCE: Levi & Korsinsky, LLPView the original press release on accesswire.com\n","length":2798,"tagName":"div"}]